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Abstract
Background: In Taiwan, a distinct ethnic group variation in incidence and mortality rates has been suggested for most
carcinomas. Our aim is to identify the role of prognostic factors associated with the survival of oral and pharyngeal
carcinoma in Taiwan.
Methods: Taiwan Cancer Registry records of 9039 subjects diagnosed with oral and pharyngeal carcinoma were
analyzed. The population was divided into three ethnic groups by residence, which were Taiwanese aborigines, Hakka
and Hokkien communities. Five-year survival rates were estimated by Kaplan-Meier methods. Ethnic curves differed
significantly by log-rank test; therefore separate models for Taiwanese aborigines, Hakka and Hokkien were carried out.
The Cox multivariate proportional hazards model was used to examine the role of prognostic factors on ethnic survival.
Results: The five-year survival rates of oral and pharyngeal carcinoma were significantly poorer for Hokkien community
(53.9%) and Taiwanese aborigines community (58.1%) compared with Hakka community (60.5%). The adjusted hazard
ratio of Taiwanese aborigines versus Hakka was 1.07 (95%CI, 0.86–1.33) for oral and pharyngeal carcinoma mortality,
and 1.16 (95%CI, 1.01–1.33) for Hokkien versus Hakka. Males had significantly poor prognosis than females. Subjects with
tongue and/or mouth carcinoma presented the worst prognosis, whereas lip carcinoma had the best prognosis. Subjects
with verrucous carcinoma had better survival than squamous cell carcinoma. Prognosis was the worst in elderly subjects,
and subjects who underwent surgery had the highest survival rate.
Conclusion: Our study presented that predictive variables in oral and pharyngeal carcinoma survival have been: ethnic
groups, period of diagnosis, gender, diagnostic age, anatomic site, morphologic type, and therapy.
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Background
Oral and pharyngeal carcinoma is one of the most com-
mon carcinomas in different ethnicities of the world. The
incidence and mortality of oral and pharyngeal carcinoma
vary widely between African-Americans and Caucasians in
the world [1,2]. Additionally, marked ethnic differences
are observed in the survival rates from oral and pharyn-
geal carcinoma, mostly reported in the United States [3,4].
Evidence from the literature indicates the survival rates in
African-Americans to be lower than Caucasians for oral
and pharyngeal carcinoma [3-5]. Oral and pharyngeal car-
cinoma is prevalent in Taiwan, where betel-quid chewing
is popular. In year 2000, for males only, the age-adjusted
incidence rate was 26.36 per 100,000 (ranked the fourth
most prevalent carcinoma) and the age-adjusted mortality
rate (11.78/100,000) was ranked fifth in terms of cancer
mortality [6].
The three major ethnic groups in Taiwan: the Hakka, Hok-
kien and indigenous Taiwanese aborigines, all present dis-
tinct health and disease patterns; for instance, the
indigenous people of Taiwan have issues with medical
deprivation. Meanwhile, the Hakka and Hokkien are
derived from a larger 'Han Chinese group', and generally,
the Hakka group has lower incidence and mortality rates
in more cancer sites than the Hokkien group as reported
from Taiwan and Singapore [7-9]. Although apparent sur-
vival differences are present in African-Americans and
Caucasians, the influence of ethnic group, as a predictor of
survival rates of oral and pharyngeal carcinoma, has not
yet been studied in Taiwan.
Conventionally, oral and pharyngeal carcinoma therapy
is a combination of surgery, radiation therapy and chem-
otherapy. Nevertheless, survival rates of oral and pharyn-
geal carcinoma were lower than most other carcinoma,
and this has not improved substantially in past years
[1,2][10]. Several prognostic factors may influence the
survival of oral and pharyngeal carcinoma, including eth-
nic group, period of diagnosis, gender, diagnostic age,
anatomic site, morphologic type, and therapy [4,5,11,12].
Therefore, the purpose of our study is to examine ethnic
differences in survival of oral and pharyngeal carcinoma,
and resulting effects of their prognostic factors.
Methods
Taiwan Carcinoma Registry (TCR) is a population-based
cancer registry with the collection of information on can-
cer patients newly diagnosed in hospitals with 50 or more
beds throughout the country. The registry is financially
supported by the National Department of Health of Tai-
wan. The registry center has an epidemiologist as the
director, a postdoctoral research fellow and eight cancer
registrars. The registry has an advisory board including 18
members with specialties in pathology, oncology, radio-
therapy, cancer registry, and public health. The cancer reg-
istry proved advantageous in evaluating the quality of
medical care and the preciseness of cancer site diagnosis.
In Taiwan, over 95% of registered cases were histologically
confirmed.
Our study population (N = 10,245) comprised of all sub-
jects diagnosed with oral and pharyngeal carcinoma in
1985–1994, recruited via the TCR system and matched
accordingly to the mortality database. The mortality data-
base, submitted standardized and immediate certificates
for each case, mandatory for physicians by the Depart-
ment of Health. So the vital statistics published by the
National Health Department of Taiwan are very complete,
with a physician confirmed rate of 99%. The subjects' sur-
vival days post-diagnosis were ascertained by active vali-
dation of their vital status until December 31, 2002.
The Morphologic types defined under the histological cat-
egories according to International Classification of Dis-
ease for Oncology (ICD-O) coding system. These
categories were verrucous carcinoma (M8051), squamous
cell carcinoma (SCC, M8052-8082), and other carcinoma.
Oral and pharyngeal carcinoma subjects were based on a
selection of only those patients with a carcinoma, exclud-
ing the adenocarcinoma (n = 310) and the lymphoma (n
= 309). Besides, subjects with unclear identification num-
bers (n = 400), birth dates (n = 5), and residence areas (n
= 54) were also excluded. All subjects were diagnosed with
histopathological confirmation. Consequently, 9039 eli-
gible subjects were included for analysis in this study.
This study was approved and reviewed by Taiwan Carci-
noma Registry, Department of Health, Executive Yuan,
Taiwan. The large-scale database was based on routine
cancer registry data, which are collected by registry center
for the intention of recording cancer. Hence, no ethical
approval was required. Before connecting and analyzing
of databases were initiated, a confidential memorandum
of agreement was signed by all researchers involved in this
study. These resulting data were confidential and analysis
process safeguarded subjects' privacy at the highest degree.
Entire names and any information of identification were
deleted from this database and replaced with arbitrary
numbers in the analysis procedure.
Descriptive variable characteristics
Factors to explain outcomes in ethnic differences from our
oral and pharyngeal carcinoma subjects, were determined
by examining the characteristics of their prognostic fac-
tors, such as: period of diagnosis, gender, diagnostic age,
anatomic site, morphologic type, and the course of ther-
apy.BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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Ethnic groups (Communities)
The population of Taiwan approaches 24 million which
consists of Hokkien (73%), mainland Chinese (13%),
Hakka (12%), and Taiwanese aborigines (2%). The Hok-
kien and Hakka populations of Taiwan migrated from
Mainland China approximately 400 and 600 years ago,
respectively. There are 10 aboriginal tribes in Taiwan, and
most of them live in rural and remote mountain areas.
The Mainland Chinese are those people who came to Tai-
wan in a wave around 50 years ago, who lived in Hokkien
communities, and integrated with the local population.
As a result, only three major community groups have been
categorized according to their resident areas: the Hakka
communities, Hokkien communities and Aborigines
communities [7]. More than 80% of all aboriginal regions
are settled with indigenous peoples. In Hakka regions,
over 80% are Hakka, and in Hokkien regions, over 85%
are Hokkien [7].
Prognostic factors
To evaluate trends in five-year survival rates from oral and
pharyngeal carcinoma, subjects were categorized as 1985–
1989 and 1990–1994 periods. The oral and pharyngeal
carcinoma data were coded according to the ninth revi-
sion of International Classification of Disease (ICD-9)
based on anatomic sites. These included malignant carci-
noma of the lip (ICD 140), tongue (ICD 141), gum (ICD
143), floor of the mouth (ICD 144), other unspecified
parts of the mouth (ICD 145), oropharynx (ICD 146),
hypopharynx (ICD 148), and other sites (ICD 149).
The choices in therapy were: surgery alone, radiation ther-
apy (RT) alone, chemotherapy (CT) alone, supportive
therapy (ST) alone; alternative combinations such as, sur-
gery + RT, surgery + CT, surgery + RT + CT, RT + CT, and
other complex therapy (including hormonal therapy, tra-
ditional Chinese medicine therapy, or unknown therapy).
Statistical analyses
The gum (ICD 143), mouth floor (ICD 144) and other
unspecified parts of mouth sites (ICD 145) were classified
into mouth groups (ICD 143–145) as they showed no dif-
ference in the survival rates. The oral and pharyngeal car-
cinoma mortalities were treated as outcomes in our
analysis. For our intent in analyzing the survival of oral
and pharyngeal carcinoma, the codes ICD 140–149
(except ICD 142; ICD 147), were classified as oral and
pharyngeal carcinoma deaths. Subjects who died from
other causes or those still alive were considered as cen-
sored observations. The ethnic curves differed signifi-
cantly using log-rank test. So subjects with oral and
pharyngeal carcinoma were segregated into Taiwanese
aborigines, Hakka and Hokkien.
Frequency distributions of demographic, clinical, and
therapy characteristics in ethnic variations were compared
by chi-square tests. Oral and pharyngeal survival post-
diagnosis was examined by Kaplan-Meier survival analy-
sis, and resulting five-year survival rates were presented.
Survival curves were examined by log-rank test in Hakka,
Hokkien and Taiwanese aborigines. Subsequent to log-log
survival plots that verified the proportion hazard assump-
tions with each predictor, the Cox multivariate propor-
tional hazards model examined the role of prognostic
factors on survival of different ethnic group. The SAS ver-
sion 8.2 statistical software was employed for all analysis
(SAS Institute Inc., Cary, NC, USA).
Results
The characteristics of prognostic factors
Table 1 depicts the distribution of prognostic characteris-
tics in Taiwan based on resident communities diagnosed
with oral and pharyngeal carcinoma in 1985–1994. In the
distribution of diagnostic period, the number of each
community did not differ significantly. However, ethnic
differences were seen in gender distribution (p < 0.0001).
Particularly, the number of diagnosed males in Hakka and
Hokkien was higher than Taiwanese aboriginal males. On
the contrary, the proportion of Taiwanese aboriginal
females was higher than Hakka and Hokkien females. The
number of diagnosed Hakka and Hokkien were in a pre-
dominantly younger age group (aged ≤ 49 years) than the
Taiwanese aborigines. Conversely, the number of diag-
nosed Taiwanese aborigines in the oldest age group (aged
≥ 70 years) was higher than Hakka and Hokkien.
In anatomic sites of oral and pharyngeal carcinoma, Tai-
wanese aborigines have the highest percentage of occur-
rence in hypopharynx and the lowest in tongue, than
other ethnic groups (p < 0.0001). There was a significance
in morphologic types among different ethnic groups.
Hakka had a lower percentage SCC than Taiwanese abo-
rigines and Hokkien. In terms of therapies, Hakka tended
to accept surgery alone (28.4%) compared to Hokkien
(24.2%) and Taiwanese aborigines (19.2%), whereas Tai-
wanese aborigines were more likely to accept ST alone.
Survival and hazard ratio of ethnic groups for oral and 
pharyngeal carcinoma
During the follow-up study period, a total of 4106
(45.4%) subjects died from oral and pharyngeal carci-
noma. Overall, the five-year survival rate of oral and pha-
ryngeal carcinoma subjects was at 54.5% (53.9% for
Hokkien, 58.1% for Taiwanese aborigines, and 60.5% for
Hakka, respectively). Figure 1 denotes the Hakka people
have the significantly longest crude survival rates (p  =
0.0051). In terms of gender, there were ethnic differences
for oral and pharyngeal carcinoma survival rates (Figure
2). Compared with Hokkien and Taiwanese aboriginalBMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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males, Hakka males had significantly better survival rates
(p  = 0.0114). Similarly, the survival rates for Hakka
females were significantly higher than for Hokkien
females and Taiwanese aborigines females (p = 0.0123).
Based on mouth site, Hakka exhibited significantly better
survival rates than Taiwanese aborigines and Hokkien
(Figure 3).
Ethnic characteristics of oral and pharyngeal carcinoma
subjects were examined by hazard ratio analysis, shown in
Table 2. In unadjusted analysis, the crude hazard ratio
found Taiwanese aborigines to have an increased risk of
death from oropharyngeal cancer, but not a statistically
significant one (unadjusted HR, 1.16; 95%CI, 0.93–1.44).
After adjusting for prognostic factors (period of diagnosis,
gender, diagnostic age, anatomic site, morphologic type,
and therapy), the adjusted HR was also at slightly
increased risk of death compared to Hakka (adjusted HR,
1.07; 95%CI, 0.86–1.33), though not statistically signifi-
cant.
Significant differences in Hokkien versus Hakka were
observed by multivariable Cox models. Hokkien have an
increased mortality from oral and pharyngeal carcinoma
compared to Hakka with the same diagnosis (unadjusted
HR, 1.25; 95%CI, 1.09–1.43). Despite controlling other
prognostic variables, the Hokkien group have a poorer
prognosis than Hakka (adjusted HR, 1.16; 95%CI, 1.01–
1.33).
Contribution of prognostic characteristics for oral and 
pharyngeal carcinoma mortalities by ethnic group
Table 3 summarizes the hazard ratios of multivariate anal-
ysis for oral and pharyngeal carcinoma mortalities in dif-
Table 1: Characteristics of oral and pharyngeal carcinoma subjects (N = 9039) at time of diagnosis in Taiwan from 1985–1994.
Ethnic group Aborigines community
(N = 302)
Hakka community
(N = 556)
Hokkien community
(N = 8181)
Characteristics N(%)a N(%)a N(%)a p Value
Period of diagnosis (yrs)
1985–1989 119(39.4) 196(35.3) 2864(35.0) 0.2908
1990–1994 183(60.6) 360(64.8) 5317(65.0)
Gender
Males 233(77.2) 467(84.0) 7280(89.0) < 0.0001
Females 69(22.9) 89(16.0) 901(11.0)
Diagnostic age (yrs)
< = 49 69(22.9) 178(32.0) 3021(36.9) < 0.0001
50–59 87(28.8) 149(26.8) 2320(28.4)
60–69 82(27.2) 142(25.5) 1812(22.2)
> = 70 64(21.2) 87(15.7) 1028(12.6)
Anatomic site
Lip 11(3.6) 19(3.4) 296(3.6) < 0.0001
Tongue 63(20.9) 162(29.1) 2333(28.5)
Mouth 128(42.4) 246(44.2) 3571(43.7)
Oropharyngeal 16(5.3) 51(9.2) 651(8.0)
Hypopharyngeal 81(26.8) 71(12.8) 1255(15.3)
Other 3(1.0) 7(1.3) 72(0.9)
Morphologic type
SCC 267(88.4) 456(82.0) 7020(85.8) 0.0229
Verrucous carcinoma 14(4.6) 24(4.3) 344(4.2)
Other carcinoma 21(7.0) 76(13.7) 817(10.0)
Therapy
Surgery alone 58(19.2) 158(28.4) 1976(24.2) 0.0188
RT alone 17(5.6) 42(7.6) 568(6.9)
CT alone 23(7.6) 48(8.6) 694(8.5)
Surgery + RT 34(11.3) 43(7.7) 756(9.2)
Surgery + CT 15(5.0) 29(5.2) 524(6.4)
RT + CT 16(5.3) 24(4.3) 440(5.4)
Surgery + RT + CT 16(5.3) 25(4.5) 344(4.2)
ST alone 22(7.3) 21(3.8) 269(3.3)
Other complex therapy 101(33.4) 166(29.9) 2610(31.9)
SCC: squamous cell carcinoma.
RT: radiation therapy; CT: chemotherapy; ST: supportive care therapy.
a May not total 100% due to rounding.BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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ferent communities. Overall, the period of diagnosis was
a significant predictor for oral and pharyngeal carcinoma
mortality in all ethnic groups, and a decreasing survival
trend was evident in 1990–1994 years. A clear gender dif-
ference emerges for Hakka and Hokkien. Increased mor-
tality was significant for males in Hakka (HR, 1.87;
95%CI, 1.18–2.97) and Hokkien (HR, 1.60; 95%CI,
1.42–1.81). In Taiwanese aborigines, there were no signif-
icant differences in gender. When considering the diag-
nostic age, upward risk trends were associated with
increasing age in Hakka and Hokkien. Results showed
anatomic sites to be significant predictors for survival in
Hokkien. Tongue (HR, 1.31; 95%CI, 1.14–1.50) and
mouth sites (HR, 1.26; 95%CI, 1.10–1.43) elevated risks
of death compared with oropharyngeal, but lip sites had a
significantly better prognosis (HR, 0.77; 95%CI, 0.61–
0.98). A tendency for this association is similar in Hakka,
even if no significance is observed.
The impact of morphologic type on death was marked,
particularly for Hakka and Hokkien. The Hakka with
other carcinoma showed the significantly lowest risk of
mortality (HR, 0.35; 95%CI, 0.20–0.62) than SCC, fol-
lowed by verrucous carcinoma. In the Hokkien, subjects
with verrucous carcinoma (HR, 0.51; 95%CI, 0.42–0.62)
and other carcinoma (HR, 0.54; 95%CI, 0.47–0.62)
showed significant reduced risks of mortality compared
with SCC type.
In the ethnic groups, significant effects in therapeutic
choices were found. In Taiwanese aborigines, subjects
who accepted RT alone, RT + CT, surgery + RT + CT, ST
alone, and other complex therapy had significant risks of
mortality compared with surgery alone. Hakka were
treated by any therapy except surgery + RT, showing signif-
icantly poor prognosis than surgery alone. Compared to
surgery alone, Hokkien accepted any therapy, all showing
significantly increased risks of mortality.
Discussion
Ethnic group variations in survival
In this population-based study, we examined the impact
of prognostic factors and survival rates from oral and pha-
ryngeal carcinoma subjects in ethnic groups in 1985–
1994. Several investigations focused on survival differ-
ences in ethnic groups with oral and pharyngeal carci-
noma. Poor survival rates were found in groups of lower
socioeconomic status and African-Americans [2-5,13].
Survival days for 302 Aborigines community (130 deaths), 556 Hakka community (215 deaths) and 8181 Hokkien community  (3761 deaths), according to oral and pharyngeal carcinoma deaths (N = 4106), which act as endpoints (p = 0.0051) Figure 1
Survival days for 302 Aborigines community (130 deaths), 556 Hakka community (215 deaths) and 8181 Hokkien community 
(3761 deaths), according to oral and pharyngeal carcinoma deaths (N = 4106), which act as endpoints (p = 0.0051).BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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(A) Survival days for 233 Aborigines community males (98 deaths), 467 Hakka community males (193 deaths) and 7280 Hokk- ien community males (3469 deaths), according to oral and pharyngeal carcinoma deaths (N = 3760), which act as endpoints (p  = 0.0114) Figure 2
(A) Survival days for 233 Aborigines community males (98 deaths), 467 Hakka community males (193 deaths) and 7280 Hokk-
ien community males (3469 deaths), according to oral and pharyngeal carcinoma deaths (N = 3760), which act as endpoints (p 
= 0.0114). (B) Survival days for 69 Aborigines community females (32 deaths), 89 Hakka community females (22 deaths) and 
901 Hokkien community females (292 deaths), according to oral and pharyngeal carcinoma deaths (N = 346), which act as end-
points (p = 0.0123).BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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Taiwanese aborigines attest to this, by residing in remote
or high mountain regions, having insufficient medical
resources, and a lower socioeconomic status. In spite of
this, our study found Taiwanese aborigines to have higher
(but not significantly so) five-year survival rates (58.1%)
compared to Hokkien (53.9%). Their medical conditions
and socioeconomic status could possibly have been amel-
iorated in recent years. In Hakka and Hokkien communi-
ties, there were significant variations. The Hakka
community exhibited the highest survival rates (60.5%)
than other communities, and compared against the Hok-
kien community, the survival rate was found to be signif-
icant. Moreover, for both males and females, Hakka
community also had significantly better survival rates
than other communities (Figure 2). After controlling for
prognostic factors, and compared to Hakka communities,
Taiwanese aborigines communities and Hokkien commu-
nities had a 1.07- and 1.16-fold of risks for oral and pha-
ryngeal carcinoma mortality, respectively. The profound
effect of communities on survival rates of oral and pha-
ryngeal carcinoma needs to be further elucidated.
Genetic predisposition and lifestyle habits were seen as
key factors in survival differences of ethnic groups with
oral and pharyngeal carcinoma [14-16]. From an article
review, molecular modifications strongly associate with
oral carcinoma, such as p53 or RAS mutations [15]. Cyto-
chrome P450 activate environmental carcinogens, and its
mutations predispose subjects to oral carcinoma [16-18].
Further, glutathione S-transferase (GST) and N-acetyl
transferase (NAT) families can be genetic determinants of
oral carcinoma [16-19]. Indeed, genetic polymorphisms
reflect the variations of oral carcinoma survival in ethnic-
ity [16]. These differentials exist in ethnic groups of Tai-
wan, and warrant consideration. Trejaut et al. indicated
Hakka and Hokkien have significant differences with the
Taiwanese aborigines in cytokine gene polymorphisms,
implicating a susceptibility or resistance to diseases [20].
Moreover, Hakka population has variations of G6PD pol-
ymorphism, and higher prevalence of alpha-thalassemia
than Hokkien[21,22] Also, between Hakka and Hokkien
populations, the Hakka appeared to have a higher fre-
quency of paraoxonase (PON) activity than Hokkien [23].
On top of genetic predispositions, diet in the Hakka may
be important in determining a subject's survival. A study
from Singapore showed lower incidence rates and relative
risks for most carcinoma sites in Hakka groups than in
Survival days of mouth site for 128 Aborigines community (67 deaths), 246 Hakka community (94 deaths) and 3571 Hokkien  community (1700 deaths), according to oral and pharyngeal carcinoma deaths (N = 1861), which act as endpoints (p = 0.0100) Figure 3
Survival days of mouth site for 128 Aborigines community (67 deaths), 246 Hakka community (94 deaths) and 3571 Hokkien 
community (1700 deaths), according to oral and pharyngeal carcinoma deaths (N = 1861), which act as endpoints (p = 0.0100).BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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Hokkien groups [8]. In a mortality analysis of Taiwan res-
idential communities, Hakka had significantly reduced
risks of carcinoma deaths than Hokkien [7]. From our lat-
est published study, significantly lower incidence and
mortality rate of oral and pharyngeal cancer were found in
the Hakka communities, when compared to the Hokkien
communities [9]. In China, a nutritional survey found
that the Hakka maintained different food habits, and were
actively aware of their health [14]. The major diet of the
Hakka is rice, fish, vegetables and fruits [14]. Diets rich in
fresh vegetables and fruits, particularly in carotene, vita-
min C, and vitamin E, are anti-oxidant and have a protec-
tive effect against oral and pharyngeal carcinoma [24].
Medical services accessibility also influences the type of
therapy received by Hakka, Hokkien and Taiwanese abo-
rigines community. Favorable therapy with surgery alone
is seen to be the highest proportion in the Hakka commu-
nity (28.4%). This explains why the Hakka subjects were
diagnosed in the early stages, and that better medical
behavior grants prognostic improvement.
In this study, the most common site for oral and pharyn-
geal carcinoma was mouth carcinoma; comparable with
other countries where betel-quid chewing is popular
[25,26]. Only the Hokkien communities with mouth car-
cinoma show significant differences in survival compared
to oropharyngeal carcinoma. According to retrospective
data from hospitals in Taiwan, betel-quid chewing absti-
nence may improve survival of oral and pharyngeal carci-
noma patients [11,12]. We found there were statistically
significant differences (p = 0.0100) among ethnic groups
in survival of mouth carcinoma (Fig. 3.). We speculate this
to be disparity in betel-quid chewing habits practiced
among ethnic groups. In Taiwan, a survey investigated the
prevalence of betel-quid chewing in 23 counties and 3
aboriginal areas [27]. It was lower in Hakka than Hokkien
communities and Taiwanese aborigines. In Taiwan, epide-
miological studies demonstrated betel-quid chewing was
an independent risk factor for oral and pharyngeal carci-
noma, and mostly mouth carcinoma [28,29]. Five-year
survival rates for mouth sites were 63.8% for Hakka,
55.7% for Taiwanese aborigines, and 54.1% for Hokkien.
In addition, the significant risks of death for mouth carci-
noma in Hokkien communities (HR, 1.26; 95%CI, 1.10–
1.43) have a high propensity to be linked to betel-quid
chewing habits, resulting in a poorer prognosis for Hokk-
ien.
Presentation of prognostic factors in survival
A significant increasing mortality trend was found in oral
and pharyngeal carcinoma subjects, between 1985–1989
and 1990–1994. Explanation for this deterioration is not
straightforward. Conceivably, the decline in survival rates
may be no improvement in earlier detection or treatment
effectiveness. Our findings concur with trends in oral and
pharyngeal carcinoma survival from other study [10]. In
Vaud Cancer Registry of Swiss canton, five-year survival
rates fell from 41% in 1974–1978 to 33% in 1979–1983
for oral cavity carcinoma, and from 45% to 39% for carci-
noma of head and neck [10]. Goldberg et al. revealed five-
year survival rates of oral and pharyngeal carcinoma sub-
jects had no marked improvement, but there was a sub-
stantial decline from 3.8% in 1974–1976 to 1981–1985
[30]. Overall, there has been no evidence presented that
oral carcinoma survival has improved appreciably in the
US [1,2,13]. In contrast, a significant trend of increasing
survival was found in Italy, as their five-year survival rates
were 32% in 1975–1978 and 51% in 1989–1993 [31].
Our striking finding in an overall declining trend of oral
and pharyngeal carcinoma survival from 1985–1989 to
1990–1994 deserves further attention.
Gender differences strongly correlate to survival rates in
Hakka and Hokkien communities, but only slightly in
Taiwanese aborigines. Males seem to suffer a deterioration
in survival, and this finding remains compatible with pre-
vious studies [1,5,11,13,32]. Nonetheless, few reports in
other countries elicited better survival rates in males, or
similar rates for both males and females [3,4,30]. In Tai-
wan, combination usage of betel-quid, alcohol and
Table 2: Unadjusted and adjusted hazard ratio for oral and pharyngeal carcinoma death in Taiwan from 1985–1994.
Oral and pharyngeal carcinoma death (N = 4106)
Ethnic group Aborigines: Hakkaa HR (95% CI) Hokkien: Hakkab HR (95% CI)
Unadjusted HR 1.16 (0.93–1.44) 1.25 (1.09–1.43)*
Adjusted HR
Adjusted for the period of diagnosis (yrs) 1.16 (0.93–1.44) 1.25 (1.09–1.43)*
Above plus gender, diagnostic age 1.18 (0.95–1.46) 1.22 (1.06–1.40)*
Above plus anatomic site, morphological type, therapy 1.07 (0.86–1.33) 1.16 (1.01–1.33)*
HR: hazard ratio; CI = confidence interval.
* Statistical significance (p < 0.05).
a Aborigines community-to-Hakka community ratio.
b Hokkien community-to-Hakka community ratio.BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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tobacco could contribute to the observed gender varia-
tions in survival [11,12]. The pattern of drinking and
smoking is similar in both genders, but betel-quid use has
been much higher in males than females [33]. Because
betel-quid chewing can cause bad breath and unsightly
red stains on the lip and teeth, females are reluctant to
develop the chewing habits. This greater prevalence of
chewing habits in males, may partially explain the poor
prognosis for males with oral and pharyngeal carcinoma
[11]. Additionally, in Taiwanese urban areas, a predomi-
nant male-to-female ratio (21:1) of chewing prevalence
was demonstrated among Kaohsiung residents [34]. Con-
versely, for Taiwanese aborigines, the betel-quid usage is a
cultural and social custom. A population survey indicates
that more women (78.7%) than men (60.6%) chew betel-
quid in aboriginal communities [35]. Hence, in our inves-
tigation, a gender difference is not obvious in Taiwanese
aborigines.
With the age diagnostic, the older age groups seemed to be
at an increased risk of death according to many articles [2-
4,11,32]. Other reports presented younger patients to be
associated with aggressive prognosis [36]. Increasing age,
especially among those older than 69 years, was a signifi-
cant risk factor in Hakka and Hokkien communities. This
might be due to poor tolerance of treatment, more likeli-
hood of being in an advanced stage and the belief that
older subjects have poorer health conditions.
Table 3: Multivariate proportional hazard ratio for oral and pharyngeal carcinoma death in Taiwan from 1985–1994.
Oral and pharyngeal carcinoma death (N = 4106)
Ethnic group Aborigines community (N = 130) Hakka community (N = 215) Hokkien community (N = 3761)
Characteristics HR(95% CI) HR(95% CI) HR(95% CI)
Period of diagnosis (yrs)
1985–1989 1.00 1.00 1.00
1990–1994 1.43(0.93–2.20) 1.55(1.13–2.13)* 1.20(1.12–1.29)*
Gender
Females 1.00 1.00 1.00
Males 0.94(0.62–1.43) 1.87(1.18–2.97)* 1.60(1.42–1.81)*
Diagnostic age (yrs)
< = 49 1.00 1.00 1.00
50–59 1.17(0.71–1.92) 1.12(0.77–1.61) 0.96(0.89–1.04)
60–69 1.24(0.74–2.08) 1.19(0.83–1.73) 0.99(0.90–1.08)
> = 70 1.05(0.59–1.87) 2.46(1.62–3.73)* 1.15(1.03–1.28)*
Anatomic site
Oropharyngeal 1.00 1.00 1.00
Lip 1.22(0.33–4.55) 0.52(0.17–1.61) 0.77(0.61–0.98)*
Tongue 0.94(0.37–2.37) 1.36(0.77–2.41) 1.31(1.14–1.50)*
Mouth 0.89(0.37–2.15) 1.18(0.67–2.07) 1.26(1.10–1.43)*
Hypopharyngeal 0.43(0.17–1.11) 0.99(0.51–1.90) 0.98(0.84–1.15)
Other 0.00-a 0.85(0.11–6.77) 0.70(0.43–1.13)
Morphologic type
SCC 1.00 1.00 1.00
Verrucous carcinoma 0.95(0.38–2.40) 0.46(0.20–1.05) 0.51(0.42–0.62)*
Other carcinoma 0.63(0.30–1.35) 0.35(0.20–0.62)* 0.54(0.47–0.62)*
Therapy
Surgery alone 1.00 1.00 1.00
RT alone 3.02(1.25–7.28)* 3.03(1.70–5.40)* 2.61(2.26–3.01)*
CT alone 1.38(0.55–3.46) 4.81(2.93–7.90)* 2.74(2.41–3.12)*
Surgery + RT 2.01(0.98–4.13) 1.56(0.85–2.84) 1.76(1.55–2.01)*
Surgery + CT 1.21(0.46–3.13) 2.40(1.30–4.45)* 1.38(1.18–1.61)*
RT + CT 5.38(2.26–12.83)* 2.97(1.55–5.67)* 3.49(3.02–4.03)*
Surgery + RT + CT 3.76(1.60–8.83)* 4.59(2.51–8.39)* 2.58(2.20–3.01)*
ST alone 3.78(1.69–8.43)* 2.55(1.11–5.86)* 3.05(2.53–3.69)*
Other complex therapy 2.96(1.57–5.59)* 2.46(1.61–3.74)* 2.09(1.89–2.30)*
SCC: squamous cell carcinoma; RT: radiation therapy; CT: chemotherapy; ST: supportive care therapy.
HR: hazard ratio; CI: confidence interval.
a No subjects died from other anatomic site.
*Statistical significance (p < 0.05).BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
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This study also found significant risk in mouth sites. For
Hokkien communities, tongue and mouth sites have an
increased risk of mortality in oral and pharyngeal carci-
noma, but lip sites had better survival rates. Some articles
reported that tongue carcinoma was more aggressive than
carcinoma of other sites [2,5,11]. Studies suggested lip
carcinomas had higher survival rates [2,5,11]. Higher sur-
vival rates for lip sites may be due to readily visible
lesions, which can be identified and treated at an earlier
stage than carcinoma from other sites. For Hakka commu-
nities, better prognosis is seen in other carcinoma. For
Hokkien communities, better prognosis is seen in verru-
cous carcinoma, and other carcinoma. A previous research
study also showed higher five-year survival rates in
patients with verrucous carcinoma [11]. Most clinicians
regard verrucous carcinoma to portend better long-term
prognosis than SCC.
Surgical resection and/or radiotherapy and chemotherapy
have been the mainstay treatment for oral and pharyngeal
carcinoma in this study. Our findings offered a prognostic
favorable effect with the option of surgical therapy alone
in Taiwanese aborigines, Hakka and Hokkien communi-
ties. Compared with surgery alone, we found aborigines
and Hokkien communities treated with RT + CT to have
consistently significant highest risks of death. However,
Hakka communities treated with CT alone suffered the
highest risk of death from oral and pharyngeal carcinoma.
Subjects who opted for early surgical intervention have a
survival advantage [4,11,12]. Some reports have indicated
that patients with radiotherapy alone have higher risks
compared to surgery alone [4,11]. In terms of therapy, the
survival of oral and pharyngeal carcinoma is strongly
influenced by the stage of carcinoma extension. Informa-
tion pertaining to stage of oral and pharyngeal carcinoma
at diagnosis is not available with Taiwan cancer registry
system, but the choice of therapy may be treated as a clin-
ical reference.
Study limitations
Although the TCR data are the best source for long-term
trends of survival in Taiwan cancer epidemiology, it still
has several limitations for our study. Clinical carcinoma
stage was unavailable from all three ethnic groups exam-
ined in this large-scale study. Only the surrogate treatment
can be considered as a clinical reference that is closely cor-
related with staging. In a recently published report, data
suggested an earlier clinical staging of cancer was eligible
for surgical resection alone or surgical reception + RT/CT.
Without therapy or treated with CT alone, RT, ST alone
may indicate they were diagnosed in advanced stages of
the disease [37]. However, the improvement in therapy
may be due to differences in carcinoma stages, rather than
differences in effectiveness of therapy methods.
Another limitation was no item of ethnicity or race on the
TCR system in Taiwan. Despite the absence of a clear def-
inition of ethnicity from TCR, previous studies suggested
that we could use residential areas as the proxy. For exam-
ple, Lu et al. compared the difference between individual
ethnicity identification and residential communities as
the proxy; the data presented a similar mortality pattern of
aborigines in Taitung county [38]. Likewise, according to
their ethnic origins and found a very similar pattern when
compared to the mortality pattern of Taiwanese residen-
tial communities, which are classified according to resi-
dential data in Ko's study [7]. In our latest published
study, we compared the ethnic differences (Aborigines,
Hakka, and Hokkien) in incidence and mortality of
oropharyngeal cancer in Taiwan according to their resi-
dential areas [9]. Hence, in this study, the possible mis-
classification of our ethnic groups should not be a serious
problem. Despite the foregoing limitations, we believe
our results represent the most comprehensive profile of
the long-term prognosis of oral and pharyngeal cancer in
Taiwan.
Conclusion
A prognosis advantage in the Hakka communities was
found in the present study. Our study suggested that pre-
dictive factors in oral and pharyngeal carcinoma survival
have been: ethnic groups, period of diagnosis, gender,
diagnostic age, anatomic site, morphologic type, and ther-
apy. These data will be useful to researchers investigating
the long-term survival trends for subjects diagnosed with
oral and pharyngeal cancer.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
PH and TY carried out the study, participated in the
sequence alignment and drafted the manuscript. PS, and
CC carried out the data compilation and drafted the man-
uscript. YH, and YC participated in the design of the study
and performed the statistical analysis. MS, PC, SL, and HP
participated in the sequence alignment. YC conceived of
the study, and participated in its design and coordination.
All authors read and approved the final manuscript.
Acknowledgements
This study was supported in part by grants from the National Health 
Research Institutes (Grant No. NHRI-CN-PD9611P) and from the Depart-
ment of Health, Executive Yuan, Taiwan.
References
1. Swango PA: Cancers of the oral cavity and pharynx in the
United States: an epidemiologic overview.  J Public Health Dent
1996, 56(6):309-318.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2007, 7:101 http://www.biomedcentral.com/1471-2407/7/101
Page 11 of 11
(page number not for citation purposes)
2. Shiboski CH, Shiboski SC, Silverman S J: Trends in oral cancer
rates in the United States, 1973-1996.  Community Dent Oral Epi-
demiol 2000, 28(4):249-256.
3. Caplan DJ, Hertz-Picciotto I: Racial differences in survival of oral
and pharyngeal cancer patients in North Carolina.  J Public
Health Dent 1998, 58(1):36-43.
4. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR: Racial
disparity in survival of patients with squamous cell carci-
noma of the oral cavity and pharynx.  Ethn Health 2001, 6(3-
4):165-177.
5. Franco EL, Dib LL, Pinto DS, Lombardo V, Contesini H: Race and
gender influences on the survival of patients with mouth can-
cer.  J Clin Epidemiol 1993, 46(1):37-46.
6. Department of Health, Taiwan: Cancer registration system
annual report.  Taiwan , Department of Health; 2000. 
7. Ko YC, Wang TN: Mortality in Taiwanese residential commu-
nities and future implications.  Taiwan Press , Jen-Dao; 1996. 
8. Lee HP, Duffy SW, Day NE, Shanmugaratnam K: Recent trends in
cancer incidence among Singapore Chinese.  Int J Cancer 1988,
42(2):159-166.
9. Ho PS, Yang YH, Shieh TY, Chen CH, Tsai CC, Ko YC: Ethnic dif-
ferences in the occurrence of oropharyngeal cancer in Tai-
wan.  Public Health 2007, epub ahead of print:. , available online 11
May 2007.
10. Franceschi S, Levi F, Vecchia C: Decline in 5-year survival rates
for cancer of head and neck.  Lancet 1992, 340(8810):47.
11. Chen PH, Ko YC, Yang YH, Lin YC, Shieh TY, Chen CH, Tsai CC:
Important prognostic factors of long-term oropharyngeal
carcinoma survivors in Taiwan.  Oral Oncol 2004, 40(8):847-855.
12. Chen YK, Huang HC, Lin LM, Lin CC: Primary oral squamous cell
carcinoma: an analysis of 703 cases in southern Taiwan.  Oral
Oncol 1999, 35(2):173-179.
13. Silverman S Jr: Demographics and occurrence of oral and pha-
ryngeal cancers. The outcomes, the trends, the challenge.  J
Am Dent Assoc 2001, 132 Suppl:7S-11S.
14. Liu XQ, Li YH: Epidemiological and nutritional research on
prevention of cardiovascular disease in China.  Br J Nutr 2000,
84 Suppl 2:S199-203.
15. Paterson IC, Eveson JW, Prime SS: Molecular changes in oral can-
cer may reflect aetiology and ethnic origin.  Eur J Cancer B Oral
Oncol 1996, 32B(3):150-153.
16. Scully C, Bedi R: Ethnicity and oral cancer.  Lancet Oncol 2000,
1(1):37-42.
17. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N,
Ikemura K, Kawamoto T: Genetic polymorphisms of tobacco-
and alcohol-related metabolizing enzymes and oral cavity
cancer.  Int J Cancer 1999, 83(5):606-609.
18. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hild-
esheim A, Chen CJ: Genetic polymorphisms of CYP2E1,
GSTM1, and GSTT1; environmental factors and risk of oral
cancer.  Cancer Epidemiol Biomarkers Prev 1997, 6(11):901-905.
19. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H: Glutath-
ione s-transferase genotypes as risk factors for head and
neck cancer.  Am J Surg 1995, 170(5):499-501.
20. Trejaut JA, Tsai ZU, Lee HL, Chen ZX, Lin M: Cytokine gene pol-
ymorphisms in Taiwan.  Tissue Antigens 2004, 64(4):492-499.
21. Yu GL, Jiang WY, Du CS, Chen LM, Lin QD, Tian QH, Zeng JB, Li SG:
Identification of G6PD gene variants from Hakka population
in Guangdong province.  Zhonghua Yi Xue Yi Chuan Xue Za Zhi
2004, 21(5):448-451.
22. Lin CK, Lee SH, Wang CC, Jiang ML, Hsu HC: Alpha-thalassemic
traits are common in the Taiwanese population: usefulness
of a modified hemoglobin H preparation for prevalence stud-
ies.  J Lab Clin Med 1991, 118(6):599-603.
23. Lin TJ, Jiang DD, Hung DZ, Yang DY, Hsu CL, Tsai MS: Paraoxonase
activities in Minnan and Hakka.  Kaohsiung J Med Sci 2002,
18(11):551-556.
24. Chainani-Wu N: Diet and oral, pharyngeal, and esophageal
cancer.  Nutr Cancer 2002, 44(2):104-126.
25. Chattopadhyay A: Epidemiologic study of oral cancer in east-
ern India.  Indian J Dermatol 1989, 34(3):59-65.
26. Thomas SJ, MacLennan R: Slaked lime and betel nut cancer in
Papua New Guinea.  Lancet 1992, 340(8819):577-578.
27. Yang YH, Chen HR, Tseng CH, Shieh TY: Prevalence rates of
areca/betel quid chewing in countries of Taiwan.  Taiwan J Oral
Med Health Sci 2002, 18(1):1-16.
28. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC: Betel quid
chewing, cigarette smoking and alcohol consumption
related to oral cancer in Taiwan.  J Oral Pathol Med 1995,
24(10):450-453.
29. IARC: Betel-quid and Areca-nut Chewing and Some Areca-
nut-derived Nitrosamines.   IARC Monographs on the Evaluation of
Carcinogenic Risks to Humans 2004, 85:1-334.
30. Goldberg HI, Lockwood SA, Wyatt SW, Crossett LS: Trends and
differentials in mortality from cancers of the oral cavity and
pharynx in the United States, 1973-1987.  Cancer 1994,
74(2):565-572.
31. Barzan L, Talamini R, Franchin G, Vaccher E, Politi D, Minatel E,
Gobitti C: Changes in presentation and survival of head and
neck carcinomas in Northeastern Italy, 1975-1998.  Cancer
2002, 95(3):540-552.
32. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman
HT:  Presentation, treatment, and outcome of oral cavity
cancer: a National Cancer Data Base report.  Head Neck 2002,
24(2):165-180.
33. Ho PS, Ko YC, Yang YH, Shieh TY, Tsai CC: The incidence of
oropharyngeal cancer in Taiwan: an endemic betel quid
chewing area.  J Oral Pathol Med 2002, 31(4):213-219.
34. Chen JW, Shaw JH: A study on betel quid chewing behavior
among Kaohsiung residents aged 15 years and above.  J Oral
Pathol Med 1996, 25(3):140-143.
35. Yang YH, Lee HY, Tung S, Shieh TY: Epidemiological survey of
oral submucous fibrosis and leukoplakia in aborigines of Tai-
wan.  J Oral Pathol Med 2001, 30(4):213-219.
36. Kuriakose M, Sankaranarayanan M, Nair MK, Cherian T, Sugar AW,
Scully C, Prime SS: Comparison of oral squamous cell carci-
noma in younger and older patients in India.  Eur J Cancer B Oral
Oncol 1992, 28B(2):113-120.
37. Chen PH, Lin YC, Tu HP, Chiang SL, Ko AM, Hsu CL, Chang YF, Ko
YC: Important prognostic factors for the long-term survival
of subjects with primary liver cancer in Taiwan: A hyperen-
demic area.  Eur J Cancer 2007, 43(6):1076-1084.
38. Lu TH, Chen AD, Lee MC, Chen IK, Hwang LJ, Chou MC: Mortality
pattern of aborigines in Taitung county.  In Public Health Quar-
terly  Volume 23. Taiwan , Graduate Institute of Public Health;
1996:27-38. 
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/7/101/pre
pub